Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric fever treatment

This article was originally published in The Tan Sheet

Executive Summary

Alternating acetaminophen (12.5 mg/kg) and ibuprofen (5 mg/kg) in young children is more effective for reducing fever than mono-therapy, a randomized, parallel-group trial in the February Archives of Pediatrics & Adolescent Medicine finds. The study was conducted in 464 children aged 6-36 months, with a follow-up period of 10 days. Children who received alternating doses every four hours for three days also received a lower mean number of doses per child in days 1-3, required 22.6% fewer doses from day 1-2 and had fewer fever recurrences on days five and ten, Michael Sarrell, MD, et al., Tel Aviv University, report. Difference in fever reduction between acetaminophen and ibuprofen groups was not statistically significant. Participants "may have been more seriously ill than most of the children who receive over-the-counter antipyretics" since they were recruited at presentation for treatment, the authors note...

You may also be interested in...



Rare Disease Advocates Lobby US Congress For FDA Center of Excellence

Number one ask is for congressional pressure to centralize rare disease expertise at the agency, but advocates also are preparing legislation that would mandate the new center.

FDA’s 2021 Budget Priorities For Cosmetics, Food Programs Include AI Use In Postmarket Oversight

FDA’s food, dietary supplement and cosmetics division seeks funding to support its artificial intelligence capabilities, including post-market surveillance and speedy interventions in instances where safety issues arise. Also of note, the agency cites UV filters’ effects on the skin microbiome as a research priority in its fiscal 2021 budget justification to Congress.

Don't Take For Granted A Patient's Role In Clinical Trials, Experts Say

Catering to patients can help make clinical trials more accessible and useful, presenters argued at a recent conference.

Topics

UsernamePublicRestriction

Register

PS099114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel